|
CCDC66 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.37139999859082E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33159999996069E-06 |
| Normal-vs-Stage2 |
2.58679999998179E-06 |
| Normal-vs-Stage3 |
2.27169999478249E-08 |
| Normal-vs-Stage4 |
2.22989999998369E-06 |
| Stage1-vs-Stage2 |
1.546380E-01 |
| Stage1-vs-Stage3 |
3.013600E-02 |
| Stage1-vs-Stage4 |
1.884160E-01 |
| Stage2-vs-Stage3 |
8.665200E-01 |
| Stage2-vs-Stage4 |
9.065200E-01 |
| Stage3-vs-Stage4 |
7.573600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.55070003691338E-09 |
| Normal-vs-AfricanAmerican |
6.395500E-03 |
| Normal-vs-Asian |
1.582010E-02 |
| Caucasian-vs-AfricanAmerican |
2.951400E-01 |
| Caucasian-vs-Asian |
1.196000E-02 |
| AfricanAmerican-vs-Asian |
4.454800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.41769999999031E-05 |
| Normal-vs-Female |
9.64000002046106E-09 |
| Male-vs-Female |
2.002000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.1228999999835E-06 |
| Normal-vs-Age(41-60Yrs) |
4.81709999999858E-07 |
| Normal-vs-Age(61-80Yrs) |
6.10890000030118E-07 |
| Normal-vs-Age(81-100Yrs) |
1.043730E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.999600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.421800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.451800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.271200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.883000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.381000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.845800E-04 |
| Classical-VS-Follicular |
7.972600E-01 |
| Classical-VS-Other |
6.005600E-01 |
| Classical-VS-Normal |
3.33090000026459E-07 |
| Tall-VS-Follicular |
3.020700E-03 |
| Tall-VS-Other |
2.386400E-02 |
| Tall-VS-Normal |
1.1991999615546E-09 |
| Follicular-VS-Other |
7.376600E-01 |
| Follicular-VS-Normal |
5.194700E-04 |
| Other-VS-Normal |
1.528970E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.29729999981998E-07 |
| Normal-vs-N1 |
1.955020E-04 |
| N0-vs-N1 |
9.475400E-01 |
|
|
